An Inhaler Comprising A Tiotropium-Containing-Composition

Patent No. EP2800567 (titled "An Inhaler Comprising A Tiotropium-Containing-Composition") was filed by Teva Pharmaceuticals on Dec 12, 2012. The application was issued on Sep 27, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
3M UNITED KINGDOM PLCJun 27, 2018VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2800567

TEVA PHARMACEUTICALS
Application Number
EP12805442A
Filing Date
Dec 12, 2012
Status
Revoked
Jan 24, 2020
Publication Date
Sep 27, 2017